Add like
Add dislike
Add to saved papers

Acute and Subchronic Toxicity of Dusky-Skinned Mushroom, Amauroderma rude (Agaricomycetes).

Our earlier work indicated that Amauroderma rude seems to have an effect on immunoregulation and tumor inhibition. However, its toxicity is not yet clear. The aim of this work is to demonstrate the acute and subchronic toxicity of A. rude in order to provide a scientific basis for its possible use as a food. The acute toxicity study (involving mice) showed that the median lethal dose of the A. rude extract was >15,000 mg/kg. In the repeated-dose 90-day oral toxicity study (involving rats), the administration of A. rude extract at 0.1 (AR0.1), 0.2 (AR0.2), and 0.4 g (AR0.4) per rat produced no significant difference in food or water consumption or changes in body weight, hematological parameters, biochemical parameters, relative organ weights, organ coefficients, or histopathology compared with the control group. Analyses of these results with data from monitoring the appearance, behavior, and health of the animals indicate that the oral administration of A. rude extract daily for 90 days does not cause subchronic toxicity.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app